Biopharma Buffer Market
Biopharma Buffer Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Biopharma Buffer Market Size and Growth
The Biopharma Buffer market is experiencing robust growth, driven by increasing biopharmaceutical production and demand for high-quality formulations. The market size is projected to reach approximately $1.2 billion by 2026, with a CAGR of around 8%. Key trends include innovations in buffer technologies and heightened focus on regulatory compliance in biomanufacturing. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Avantor
◍ Alfa Aesar (Thermo Fisher)
◍ Merck
◍ Lonza
◍ Bio-Rad
◍ BD
◍ GE Healthcare
◍ Promega Corporation
◍ Hamilton Company
◍ XZL BIO-TECHNOLOGY
◍ SRL
The biopharma buffer market features key players like Avantor, Merck, and Lonza, providing essential buffers for drug development. These companies enhance market growth through innovative products, expanding portfolios, and offering tailored solutions. Notable sales figures include:
- Merck: $24 billion
- Thermo Fisher: $30 billion
- BD: $20 billion
Request Sample Report
Market Segmentation
By Application
Research Institution
Pharmaceutical Industry
Others
Request Sample Report
By Product
Phosphates Type
Acetates Type
TRIS Type
Others
Market Growth
Request Sample Report
$ X Billion USD
